← FDA Drug Approvals (Drugs@FDA)

SAXAGLIPTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PAR PHARM · Approved 2016-08-17

Drug application

FDA Application #

ANDA205959

Application type

Abbreviated New Drug Application (Generic)

Brand name

SAXAGLIPTIN

Generic name

Saxagliptin

Active ingredients

SAXAGLIPTIN

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

PAR PHARM

First approval

2016-08-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown